We offer much greater flexibility [than larger firms]; as a small company there is direct contact with the project’s leaders and management and that allows us…
In Conversation
Morocco is a very attractive country in terms of investment, given its stable currency, good infrastructure, industrial production capacities, and connectivity with Europe and the rest…
Every day, 100,000 patients use our medicines. Our products are present in pharmacies as well as the public market through the tenders of the Ministry of…
Beneluxa is a first collaborative step towards more balance in the pharmaceutical market. Our goal is to ensure timely access and affordability of medicines for our…
More certainty, a longer-term vision of what is going to happen, and a consideration of how all stakeholders can benefit are needed [in Mexican healthcare]
What India offers is a focus on the rapidly expanding lower middle class with high quality, low-cost goods and services - a segment not typically addressed…
Micro-immunotherapy was the discovery of a Belgian doctor therefore it is natural that Labo’Life has always had ties with the country. However, the significance of Belgium…
We have developed different products for every region because snakes, scorpions and spiders are different in every place. Our vision is for no-one to suffer or…
In the face of rising sustainability challenges and the increase of chronic diseases, having solidarity between all stakeholders – mutualities, physicians, pharma industry, and health authorities…
We have a very compelling story in the US, which revolves around creating affordable access to complex medications in a reliable and safe way
To continue evolving the business, we need to continue focusing on Saudi Arabia and the Gulf markets, which is where I see the most growth potential,…
In the biotech/agro and foodtech area, Belgium and Flanders are in a very dynamic and positive period and we expect to stay a very attractive region…
